Annual Congress Stockholm 2002

Saturday, 14.09.2002
Sunday, 15.09.2002
Monday, 16.09.2002
Tuesday, 17.09.2002
Wednesday, 18.09.2002

Citations should be made in the following way: Authors. Title. Eur Respir J 2002; 20: Suppl. 38, abstract number.

Material from 2002:

3388 Abstracts
6 Slide presentations
5 Handouts

Material from 2002: Show

Thoracic oncology: clinical management

Poster Discussion
Chairs: V. Ninane (Brussels, Belgium), K. Zarogoulidis (Thessaloniki, Greece)

Download all media

Low dose CT scanning for early lung cancer detection in an Irish population - results of baseline R. E. MacRedmond, Palcad Study Group (Dublin, Ireland)
Fluorescence bronchoscopy for detection of clinically significant lesions M. Bruyneel, P. Pierard, B. Martin, J. M. Verdebout, J. Faber, J. Hutsebaut, M. Richez, J. P. Sculier, V. Ninane (Brussels, Charleroi, Belgium)
Combination of autofluorescence bronchoscopy and argon plasma coagulation enables less extensive resection of radiographic occult lung cancer B. Schuurman, T. G. Sutedja (Amsterdam, The Netherlands)
Surveillance bronchoscopy of pre-invasive lesions of the bronchus A. K. Banerjee, N. Foster, R. H. Pamela, G. Jeremy (Cambridge, London, United Kingdom)
Comparison of diagnostic yield of endobronchial washing before and after forceps biopsy and brushing in bronchoscopy for pulmonary malignant tumors M. A. van der Drift, E. B. J. M. Thunnissen, J. P. Janssen (Nijmegen, The Netherlands)
Cellular atypia in bronchial washings and risk of bronchogenic carcinoma C. M. O'Kane, D. F. McAuley, H. Elliot, J. MacMahon (Belfast, United Kingdom)
Long term survival after resection for non small cell lung cancer significance of hormonal receptors T. N. Kontakiotis, A. Paapazoglou, O. Antonoglou, P. Spyrou, M. Christoforidis, L. Sakas, T. Kostandinidis, D. Papakosta, K. Zarogoulidis, D. Patakas (Thessaloniki, Greece)
Smoking as a prognostic factor in lung cancer patients. Population based study on 20561 cases E. Radzikowska, K. Roszkowski, P. Glaz (Warsaw, Poland)
Is gender a prognostic factor in long term survival non-small cell lung cancer? J. M. Chatkin, C. M. Abreu, T. O. Crossetti, J. A. Pinto, G. Chatkin, M. Wagner, D. A. Padilha, C. C. Fritscher (Porto Alegre, Brazil)
Detection of bone metastases in patients with NSCLC M. Yaman, S. Erturan, G. Aydin, I. Talasli, A. N. Annakkaya, S. Cömert, E. Duman (Istanbul, Turkey)
Estimation of the mediastinal involvement probability in lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy? A. Lavole, P. Giraud, Y. De Rycke, N. Mounier, B. Milleron, J. M. Cosset (Paris, France)
Adenovirus-mediated interferon-beta gene therapy inhibits tumor growth and inhibits metastatic lung tumors in mice R. Wiewrodt, M. Odaka, P. DeLong, T. Tanaka, V. Kapoor, K. Amin, L. R. Kaiser, S. M. Albelda (Philadelphia, United States Of America; Mainz, Germany)
Randomized phase III-trial of platinum- vs. non-platinum-based chemotherapy in stage IV non-small cell lung cancer B. Fischer, M. Sebastian, W. Eberhardt, A. Mohn-Staudner, W. Pfeifer, F. Kummer, S. Schmeikal, G. Heinz, A. Stahl, P. Micke, R. Buhl, R. Pirker (Mainz, Essen, Leverkusen, Germany; Vienna, Linz, Grimmenstein, Austria)
A phase II study with gemcitabine (GEM) plus irinotecan (CPT11) in malignant mesothelioma (MM): preliminary report G. Rinaldi, V. Ferrari, A. Caprioli, G. Bozzola, G. Marini, G. F. Tassi (Brescia, Italy)
A phase II study of docetaxel in combination with carboplatin in the treatment of non-small cell lung cancer patients K. Zarogoulidis, A. Xafenias, P. Panousis, T. Kontakiotis, D. Iakovidis, D. Patakas (Thessaloniki, Greece)
Concurrent paclitaxel, carboplatin and radiation therapy for locally advanced non-small cell lung cancer (NSCLC), a phase II multi-institutional trial Y. Horiuchi, M. Kawasaki, H. Yamasaki, K. Ninomiya, S. Takeo, S. Hayashi, T. Ohshima, M. Kuba, Y. Nakanishi, N. Hara (Fukuoka, Japan)
Specific features of small cell lung cancer in women: social characteristics, medical history, management and survival. A retrospective study of the 967 cases diagnosed in Bas-Rhin (Eastern France) between 1981 and 1994 B. Mennecier, L. Moreau, M. P. Lebitasy, R. Kessler, G. Pauli, E. Quoix (Strasbourg, France)
Carboplatin (C), paclitaxel (T) and etoposide (E) and early concurrent thoracic radiotherapy (TRT) for patients with limited disease small cell lung cancer (LD-SCLC): a Dutch multicentre phase 2 study J. P. van Meerbeeck, J. Belderbos, N. Van Zandwijk, S. Senan, O. Dalesio, H. B. Kwa, A. van Bochove, C. Weenink, W. Strankinga, P. Baas (Rotterdam, Amsterdam, Zaandam, Haarlem, The Netherlands)
Predictors of survival in patients undergoing radical surgery for malignant mesothelioma J. G. Edwards, K. J. O'Byrne, D. A. Waller (Leicester, United Kingdom)
Multimodal therapy in malignant pleural mesothelioma (MPM) M. H. Serke, N. Schoenfeld, D. Kaiser, A. Fisseler-Eckhoff, R. Loddenkemper (Berlin, Germany; Berlin)